Cargando…

The Mitragyna speciosa (Kratom) Genome: a resource for data-mining potent pharmaceuticals that impact human health

Mitragyna speciosa (kratom) produces numerous compounds with pharmaceutical properties including the production of bioactive monoterpene indole and oxindole alkaloids. Using a linked-read approach, a 1,122,519,462 bp draft assembly of M. speciosa “Rifat” was generated with an N50 scaffold size of 1,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brose, Julia, Lau, Kin H, Dang, Thu Thuy Thi, Hamilton, John P, Martins, Lívia do Vale, Hamberger, Britta, Hamberger, Bjoern, Jiang, Jiming, O’Connor, Sarah E, Buell, C Robin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Genome Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759815/ https://www.ncbi.nlm.nih.gov/pubmed/33677570 http://dx.doi.org/10.1093/g3journal/jkab058

Ejemplares similares

Kratom (Mitragyna speciosa)-Induced Hepatitis
por: Allison, Devin R., et al.
Publicado: (2022)

A Case of Hyperkalemia Induced by Kratom (Mitragyna speciosa)
por: Torres-Ortiz, Aldo, et al.
Publicado: (2022)

Association between kratom (Mitragyna speciosa) use and metabolic syndrome
por: La-up, Aroon, et al.
Publicado: (2022)

Investigating the Impact of Kratom (Mitragyna speciosa) Use Upon Male Sexual Health
por: Deebel, Nicholas A, et al.
Publicado: (2023)

Effects of Nutrient Fertility on Growth and Alkaloidal Content in Mitragyna speciosa (Kratom)
por: Zhang, Mengzi, et al.
Publicado: (2020)

Clinical Implications of Kratom (Mitragyna speciosa) Use: a Literature Review
por: Prevete, Elisabeth, et al.
Publicado: (2023)

Kratom (Mitragyna speciosa) and COVID-19: How about the current evidence?
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Lipid profile of regular kratom (Mitragyna speciosa Korth.) users in the community setting
por: Leong Bin Abdullah, Mohammad Farris Iman, et al.
Publicado: (2020)

Variations in mitragynine content in the naturally growing Kratom (Mitragyna speciosa) population of Thailand
por: Leksungnoen, Nisa, et al.
Publicado: (2022)

Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada
por: Ng, Jeremy Y., et al.
Publicado: (2021)

The Adverse Cardiovascular Effects and Cardiotoxicity of Kratom (Mitragyna speciosa Korth.): A Comprehensive Review
por: Leong Bin Abdullah, Mohammad Farris Iman, et al.
Publicado: (2021)

Can Kratom (Mitragyna speciosa) Alleviate COVID-19 Pain? A Case Study
por: Metastasio, Antonio, et al.
Publicado: (2020)

Health Effects Associated With Kratom (Mitragyna speciosa) and Polysubstance Use: A Narrative Review
por: Striley, Catherine W, et al.
Publicado: (2022)

Assessment of the possible health risks associated with the consumption of botanical preparations of Mitragyna speciosa (kratom)
por: Papadi, Georgia, et al.
Publicado: (2022)

Current and Future Potential Impact of COVID-19 on Kratom (Mitragyna speciosa Korth.) Supply and Use
por: Singh, Darshan, et al.
Publicado: (2020)

Plant growth and phytoactive alkaloid synthesis in kratom [Mitragyna speciosa (Korth.)] in response to varying radiance
por: Zhang, Mengzi, et al.
Publicado: (2022)

Inhibition of α-Glucosidase and Pancreatic Lipase Properties of Mitragyna speciosa (Korth.) Havil. (Kratom) Leaves
por: Limcharoen, Thanchanok, et al.
Publicado: (2022)

Seasonal and Geographic Variation in Alkaloid Content of Kratom (Mitragyna speciosa (Korth.) Havil.) from Thailand
por: Sengnon, Narumon, et al.
Publicado: (2023)

Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions
por: Todd, D. A., et al.
Publicado: (2020)

Assessment of Cardiovascular Functioning Among Regular Kratom (Mitragyna speciosa Korth) Users: A Case Series
por: Leong Bin Abdullah, Mohammad Farris Iman, et al.
Publicado: (2021)

Kratom ( Mitragyna speciosa ) Validation: Quantitative Analysis of Indole and Oxindole Alkaloids Reveals Chemotypes of Plants and Products
por: Manwill, Preston K., et al.
Publicado: (2022)

A Chromosome-Scale Genome Assembly of Mitragyna speciosa (Kratom) and the Assessment of Its Genetic Diversity in Thailand
por: Pootakham, Wirulda, et al.
Publicado: (2022)

Accelerated Solvent Extractions (ASE) of Mitragyna speciosa Korth. (Kratom) Leaves: Evaluation of Its Cytotoxicity and Antinociceptive Activity
por: Goh, Yong Sean, et al.
Publicado: (2021)

Clinical Pharmacokinetic Assessment of Kratom (Mitragyna speciosa), a Botanical Product with Opioid-like Effects, in Healthy Adult Participants
por: Tanna, Rakshit S., et al.
Publicado: (2022)

Acute, Sublethal, and Developmental Toxicity of Kratom (Mitragyna speciosa Korth.) Leaf Preparations on Caenorhabditis elegans as an Invertebrate Model for Human Exposure
por: Hughes, Samantha, et al.
Publicado: (2022)

Exploring of cardiac autonomic activity with heart rate variability in long-term kratom (Mitragyna speciosa Korth.) users: a preliminary study
por: Saengmolee, Wanumaidah, et al.
Publicado: (2022)

First Report of Meloidogyne Incognita Infecting Mitragyna Speciosa in the United States
por: Habteweld, Alemayehu, et al.
Publicado: (2022)

Following “the Roots” of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries
por: Cinosi, Eduardo, et al.
Publicado: (2015)

Metabolomics data of Mitragyna speciosa leaf using LC-ESI-TOF-MS
por: Veeramohan, Rubashiny, et al.
Publicado: (2018)

Mitragyna speciosa: Clinical, Toxicological Aspects and Analysis in Biological and Non-Biological Samples
por: Meireles, Vânia, et al.
Publicado: (2019)

Leaf Anatomy and Micromorphology Characteristics of Ketum [Mitragyna speciosa (Korth.) Havil.] (Rubiaceae)
por: Ghazalli, Mohd Norfaizal, et al.
Publicado: (2021)

Effect of Green and Red Thai Kratom (Mitragyna speciosa) on pancreatic digestive enzymes (alpha-glucosidase and lipase) and acetyl-carboxylase 1 activity: A possible therapeutic target for obesity prevention
por: Janthongkaw, Atikarn, et al.
Publicado: (2023)

Understanding the Physicochemical Properties of Mitragynine, a Principal Alkaloid of Mitragyna speciosa, for Preclinical Evaluation
por: Ramanathan, Surash, et al.
Publicado: (2015)

Differentiation of Mitragyna speciosa, a narcotic plant, from allied Mitragyna species using DNA barcoding-high-resolution melting (Bar-HRM) analysis
por: Tungphatthong, Chayapol, et al.
Publicado: (2021)

Antinociceptive Action of Isolated Mitragynine from Mitragyna Speciosa through Activation of Opioid Receptor System
por: Shamima, Abdul Rahman, et al.
Publicado: (2012)

Subchronic toxicity study of standardized methanolic extract of Mitragyna speciosa Korth in Sprague-Dawley Rats
por: Ilmie, Mohd U., et al.
Publicado: (2015)

Genome assembly of Chiococca alba uncovers key enzymes involved in the biosynthesis of unusual terpenoids
por: Lau, Kin H, et al.
Publicado: (2020)

The evaluation of antinociceptive activity of alkaloid, methanolic, and aqueous extracts of Malaysian Mitragyna speciosa Korth leaves in rats
por: Sabetghadam, Azadeh, et al.
Publicado: (2010)

Comparative metabolomics analysis reveals alkaloid repertoires in young and mature Mitragyna speciosa (Korth.) Havil. Leaves
por: Veeramohan, Rubashiny, et al.
Publicado: (2023)

Effects of Mitragynine and a Crude Alkaloid Extract Derived from Mitragyna speciosa Korth. on Permethrin Elimination in Rats
por: Srichana, Kachamas, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4phqjqmlfspneqj16e5a9oef7j